Close
Smartlab Europe
Inizio Ignite

Press Releases

AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new facility at its Copenhagen, Denmark site. This multipurpose facility will allow AGC Biologics to increase its capacity and space to accommodate...

Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world

Zydus Cadila announced that the company has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19. ZyCoV-D is a three dose vaccine which will...

Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United States

Zydus Pharmaceuticals Inc, USA (a 100% subsidiary of Cadila Healthcare Limited (Zydus Cadila), a leading innovation-driven, global healthcare provider, has signed a license and supply agreement with CHEMI SpA (“CHEMI”) of Italy, a subsidiary of Italfarmaco Group, to launch...

IAG Cargo reaches 10 million vaccine milestone, as it supports Crown Agents and UNICEF complete key shipments for vaccine equity

IAG Cargo, the cargo division of International Airlines Group (IAG) has announced that it has now transported over 10 million COVID vaccines, supporting global efforts in the fight against COVID-19. This includes a 4 million dose shipment to Abuja,...

Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop and Promote High Payload Dry Powder Inhaler

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that they have entered into an agreement with Pharmaxis, a clinical stage drug developer, under which Aptar Pharma has the option to acquire...

Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the U.S. FDA has approved an update to the emergency use authorization for the Moderna COVID-19 vaccine (mRNA-1273) to include a third dose for immunocompromised...

Moderna Announces Supply Agreement with Canada for Expanded Supply of Moderna’s COVID-19 Vaccine in 2022, in 2023 and in 2024

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced a revised supply agreement with the Government of Canada for up to 105 million doses of Moderna’s COVID-19 vaccine and its booster vaccine candidate, if authorized,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »